Popular Pre-Market Trades in US Stocks
Lianhe Sowell, up 10.37% in pre-market trading, has no significant news recently. Trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Nebius is up 3.15% in pre-market trading. Based on recent news,
<ol>
<li>
On December 16, Nebius experienced an unexpected violent surge during trading, with a significant increase in trading volume and clear capital dominance. The technical indicators show a short-term new high squeeze effect. If the volume continues to increase, it is expected to challenge the psychological level of $24.5-$25. Source: Zhitong Finance
</li>
<li>
On December 15, analyst Gregory P Miller expressed an optimistic view on Nebius, with a target price of $175, believing that the construction of GPU clusters will create significant value for the company, expecting a 87.25% upside in the stock price. Source: Citizens JMP
</li>
<li>
On December 14, Nebius's third-quarter financial report showed that the company needs to achieve revenue growth after activating its infrastructure, with management expecting to reach EBITDA breakeven within the next 12 to 24 months. Source: YCharts TMT sector ETF funds are flowing back, and industry rotation is driving emotional resonance.
</li>
</ol>
Top Gainers in Pre-Market US Stocks
Agape ATP is up 89.33% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 17, Agape ATP announced it will focus on the diversified development of health and sustainable green energy businesses to provide sustainable equity performance value. This move may enhance investor confidence and drive up the stock price. Source: Benzinga
</li>
<li>
On December 17, Agape ATP's third-quarter revenue fell to $370,590, down from $465,500 in the second quarter, with a per-share loss maintained at $0.01. Despite the weak financial performance, market expectations for its future strategy may drive the stock price up. Source: Benzinga
</li>
<li>
On December 17, Benzinga's stock ranking showed that ATPC stock has exhibited a negative price trend across all time frames. However, recent strategic adjustments may change market expectations, leading to stock price fluctuations. Source: Benzinga Increased attention on health and green energy sectors.
</li>
</ol>
Aditxt is up 47.16% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 15, Aditxt announced a $20 million financing, which led to a drop in stock price. This raised market concerns about the company's capital needs, causing the stock price to decline.
</li>
<li>
As of December 17, Aditxt's stock price has fallen 99.97% year-to-date, with the market holding a negative view on its long-term performance. According to data from Benzinga, the stock price fell 1.39% at Tuesday's close, indicating a continued negative trend
On December 17, despite the long-term poor performance of the stock price, Aditxt's pre-market price rose by 47.16%, possibly influenced by short-term market sentiment or trading activity. The biotechnology industry has been quite volatile recently and requires attention.
</li>
</ol>
cbdMD rose 40.56% in pre-market trading. Based on recent news,
<ol>
<li>
On December 17, news of U.S. President Trump's executive order emerged. Although the order will not legalize marijuana, states will still control its regulatory approach. As a supplier of CBD oil products derived from marijuana, cbdMD's stock price increased as a result.
</li>
<li>
On December 16, after a 19.17% increase in the previous day, cbdMD's stock price rose again by 47.55% in pre-market trading. This upward trend began earlier this week when reports of the executive order started circulating.
</li>
<li>
On December 15, trading activity for cbdMD stocks significantly increased, with a trading volume exceeding 17.8 million shares that day, while the three-month average daily trading volume was 7.54 million shares. The marijuana industry has been quite volatile recently due to policy news
</li>
</ol>

LHSW

NBIS

Lianhe Sowell pre-market up 10.37%; Nebius pre-market up 3.15%; Agape ATP pre-market up 89.33%; Aditxt pre-market up 47.16%; cbdMD pre-market up 40.56%

Pre-market hot trades in US stocks: Lianhe Sowell up 10.37% in pre-market; Nebius up 3.15% in pre-market